DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Cervical Dysplasia Market: By Type (low-grade SIL, or LSIL (Squamous Intraepithelial Lesion), high-grade SIL, or HSIL, Cancer Bound SIL, Atypical glandular cells (AGUS)) Strategic Analysis(Value Chain, Pricing Analysis) & By Geography-Forecast (2014-" report to their offering.
This report identifies the cervical dysplasia market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape and other key aspects with respect to cervical dysplasia market.
The report covers major types of cervical dysplasia, some of the major cervical dysplasia types are as follows: low-grade SIL, or LSIL (Squamous Intraepithelial Lesion), high-grade SIL, or HSIL, Cancer Bound SIL and Atypical glandular cells (AGUS)
This report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for cervical dysplasia in each of the region.
Some of the major companies' profiles in detail are as follows:
- Helix BioPharma Corp.
- PDS Biotechnology Corporation
- GlaxoSmithKline plc
- Inovio Biomedical Corporation
- Photocure ASA
1. Cervical Dysplasia - Market Overview
2. Executive Summary
3. Cervical Dysplasia Market Landscape
4. Cervical Dysplasia - Market Forces
5. Cervical Dysplasia Market - Strategic Analysis
6. Global Cervical Dysplasia Market By Type
7. Global Cervical Dysplasia Market By Geography
8. Cervical Dysplasia - Market Entropy
9. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/96tq3s/cervical